eHealth, Inc. (EHTH) News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{
  "main_header": {
    "sid": 1153531,
    "name": "eHealth, Inc.",
    "stock_name": "eHealth, Inc.",
    "full_name": "eHealth, Inc.",
    "name_url": "stocks-analysis/ehealth-inc",
    "exchange": 210,
    "exchangecode": "NAS",
    "country_id": 2,
    "currency": "USD",
    "cmp": "4.10",
    "chg": 0.07,
    "chgp": "1.74%",
    "dir": 1,
    "prev_price": "4.03",
    "mcapval": "166.30",
    "mcap": "Micro Cap",
    "scripcode": "",
    "symbol": "",
    "ind_name": "Insurance",
    "ind_code": 4865,
    "indexname": "S&P 500",
    "isin": "US28238P1093",
    "curr_date": "Dec 04",
    "curr_time": "",
    "bse_nse_vol": "499.24 k",
    "exc_status": "Active",
    "traded_date": "Dec 04, 2025",
    "traded_date_str": "2025 12 04",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/ehealth-inc-1153531-210&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Is eHealth, Inc. overvalued or undervalued?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-ehealth-inc-overvalued-or-undervalued-3673378",
        "imagepath": "",
        "date": "2025-11-05 11:10:13",
        "description": "As of 31 October 2025, the valuation grade for eHealth, Inc. has moved from attractive to very attractive, indicating a strong improvement in its valuation outlook. The company appears to be undervalued, supported by a P/E ratio of 6, a price-to-book value of 0.20, and an EV to EBITDA ratio of 0.40, all of which suggest that the stock is trading at a significant discount relative to its earnings and assets. \n\nIn comparison to its peer, Abacus Life, Inc., which has a much higher P/E ratio of 164.30 and an EV to EBITDA of 18.86, eHealth, Inc. stands out as a more compelling investment opportunity. Additionally, the PEG ratio of 0.02 further emphasizes its undervaluation relative to growth expectations. However, it is worth noting that eHealth's recent stock performance has lagged behind the S&P 500, with a year-to-date return of -47.55% compared to the index's 16.30%, although it has shown a positive return o..."
      },
      {
        "title": "eHealth, Inc. Adjusts Valuation Amid Positive Financial Developments and Technical Trends",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/ehealth-inc-stock-rating-upgraded-to-hold-amid-improved-valuation-metrics-3671293",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/eHealthInc_mojoScore_3671293.png",
        "date": "2025-11-04 16:58:21",
        "description": "eHealth, Inc. has recently experienced an evaluation adjustment reflecting changes in its financial metrics, including a revised valuation grade. Key indicators such as the P/E ratio and price-to-book value suggest a compelling valuation landscape. Despite facing challenges, high institutional holdings may provide some stability."
      },
      {
        "title": "Is eHealth, Inc. overvalued or undervalued?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-ehealth-inc-overvalued-or-undervalued-3670571",
        "imagepath": "",
        "date": "2025-11-04 11:16:09",
        "description": "As of 31 October 2025, the valuation grade for eHealth, Inc. has moved from attractive to very attractive, indicating a strong improvement in its perceived value. The company appears to be undervalued, given its low P/E ratio of 6, a price-to-book value of 0.20, and an EV to EBITDA ratio of 0.40, which are significantly lower than the industry averages. In comparison, Abacus Life, Inc., a peer in the insurance industry, has a much higher P/E ratio of 164.30, highlighting eHealth's relative undervaluation.\n\nDespite recent challenges reflected in its year-to-date return of -44.89% compared to the S&P 500's 16.30%, eHealth has shown resilience with a 3-year return of 85.00%, outperforming the benchmark's 76.66%. This suggests that while the stock has faced short-term setbacks, its long-term potential remains strong, reinforcing the narrative of undervaluation...."
      },
      {
        "title": "Is eHealth, Inc. overvalued or undervalued?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-ehealth-inc-overvalued-or-undervalued-3666140",
        "imagepath": "",
        "date": "2025-11-03 11:15:24",
        "description": "As of 31 October 2025, the valuation grade for eHealth, Inc. moved from attractive to very attractive, indicating a strong improvement in its perceived value. The company appears to be undervalued, supported by a P/E ratio of 6, a Price to Book Value of 0.20, and an EV to EBITDA of 0.40. In comparison, its peer Abacus Life, Inc. has a significantly higher P/E ratio of 164.30, highlighting the relative undervaluation of eHealth.\n\nWith a PEG ratio of 0.02, eHealth, Inc. shows potential for growth at a low price, further reinforcing its attractive valuation. Although return data is not available for a direct comparison with the S&P 500, the substantial difference in valuation ratios suggests that eHealth may offer a compelling investment opportunity relative to its peers...."
      },
      {
        "title": "Is eHealth, Inc. overvalued or undervalued?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-ehealth-inc-overvalued-or-undervalued-3664275",
        "imagepath": "",
        "date": "2025-11-02 11:08:50",
        "description": "As of 31 October 2025, the valuation grade for eHealth, Inc. has moved from attractive to very attractive, indicating a strong positive shift in its perceived value. The company appears to be undervalued, supported by key ratios such as a P/E ratio of 6, a Price to Book Value of 0.20, and an EV to EBITDA of 0.40. In comparison, its peer Abacus Life, Inc. has a significantly higher P/E ratio of 164.30, highlighting eHealth's relative undervaluation within the industry.\n\nDespite recent stock performance showing a year-to-date decline of 44.79% compared to a 16.30% gain in the S&P 500, eHealth's long-term returns over three years of 93.66% versus 76.66% for the benchmark suggest potential for recovery and growth. This combination of low valuation ratios and favorable long-term performance reinforces the argument that eHealth, Inc. is currently undervalued...."
      },
      {
        "title": "Is eHealth, Inc. technically bullish or bearish?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-ehealth-inc-technically-bullish-or-bearish-3546459",
        "imagepath": "",
        "date": "2025-09-20 19:33:23",
        "description": "As of 12 September 2025, the technical trend for eHealth, Inc. has changed from sideways to mildly bearish. The current stance is mildly bearish, driven by daily moving averages indicating bearish momentum and weekly Bollinger Bands showing a bearish signal. While the MACD is mildly bullish on both weekly and monthly time frames, it is countered by the overall bearish signals from the moving averages and Bollinger Bands. The KST shows mild bullishness on the weekly and bullishness on the monthly, but the Dow Theory indicates no trend in both time frames. \n\nIn terms of performance, eHealth has underperformed the S&P 500 significantly across multiple periods, with a year-to-date return of -57.87% compared to the S&P 500's 12.22%, and a 5-year return of -94.99% versus the S&P 500's 96.61%...."
      },
      {
        "title": "Is eHealth, Inc. overvalued or undervalued?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-ehealth-inc-overvalued-or-undervalued-3543035",
        "imagepath": "",
        "date": "2025-09-20 18:08:53",
        "description": "As of 7 July 2025, the valuation grade for eHealth, Inc. has moved from attractive to very attractive, indicating a strong improvement in its valuation outlook. The company appears to be undervalued, with a P/E ratio of 6, a Price to Book Value of 0.20, and an EV to EBITDA ratio of 0.40, all suggesting that the stock is trading at a significant discount compared to its earnings and asset value. In comparison, peer Abacus Life, Inc. has a much higher P/E ratio of 164.30, highlighting eHealth's relative undervaluation within the insurance industry.\n\nDespite its attractive valuation metrics, eHealth's recent stock performance has been poor, with a year-to-date return of -57.87% compared to the S&P 500's 12.22%. This stark contrast in returns reinforces the notion that the stock may be undervalued, as the market has not yet recognized its potential despite the favorable valuation ratios...."
      }
    ],
    "total": 12,
    "sid": "1153531",
    "stock_news_url": "https://www.marketsmojo.com/news/ehealth-inc-1153531"
  },
  "announcements": "",
  "corporate_actions": {
    "msg": "No corporate action Found"
  }
}

News and Views

Is eHealth, Inc. overvalued or undervalued?

2025-11-05 11:10:13

As of 31 October 2025, the valuation grade for eHealth, Inc. has moved from attractive to very attractive, indicating a strong improvement in its valuation outlook. The company appears to be undervalued, supported by a P/E ratio of 6, a price-to-book value of 0.20, and an EV to EBITDA ratio of 0.40, all of which suggest that the stock is trading at a significant discount relative to its earnings and assets. In comparison to its peer, Abacus Life, Inc., which has a much higher P/E ratio of 164.30 and an EV to EBITDA of 18.86, eHealth, Inc. stands out as a more compelling investment opportunity. Additionally, the PEG ratio of 0.02 further emphasizes its undervaluation relative to growth expectations. However, it is worth noting that eHealth's recent stock performance has lagged behind the S&P 500, with a year-to-date return of -47.55% compared to the index's 16.30%, although it has shown a positive return o...

eHealth, Inc. Adjusts Valuation Amid Positive Financial Developments and Technical Trends

2025-11-04 16:58:21

eHealth, Inc. has recently experienced an evaluation adjustment reflecting changes in its financial metrics, including a revised valuation grade. Key indicators such as the P/E ratio and price-to-book value suggest a compelling valuation landscape. Despite facing challenges, high institutional holdings may provide some stability.

Is eHealth, Inc. overvalued or undervalued?

2025-11-04 11:16:09

As of 31 October 2025, the valuation grade for eHealth, Inc. has moved from attractive to very attractive, indicating a strong improvement in its perceived value. The company appears to be undervalued, given its low P/E ratio of 6, a price-to-book value of 0.20, and an EV to EBITDA ratio of 0.40, which are significantly lower than the industry averages. In comparison, Abacus Life, Inc., a peer in the insurance industry, has a much higher P/E ratio of 164.30, highlighting eHealth's relative undervaluation. Despite recent challenges reflected in its year-to-date return of -44.89% compared to the S&P 500's 16.30%, eHealth has shown resilience with a 3-year return of 85.00%, outperforming the benchmark's 76.66%. This suggests that while the stock has faced short-term setbacks, its long-term potential remains strong, reinforcing the narrative of undervaluation....

Is eHealth, Inc. overvalued or undervalued?

2025-11-03 11:15:24

As of 31 October 2025, the valuation grade for eHealth, Inc. moved from attractive to very attractive, indicating a strong improvement in its perceived value. The company appears to be undervalued, supported by a P/E ratio of 6, a Price to Book Value of 0.20, and an EV to EBITDA of 0.40. In comparison, its peer Abacus Life, Inc. has a significantly higher P/E ratio of 164.30, highlighting the relative undervaluation of eHealth. With a PEG ratio of 0.02, eHealth, Inc. shows potential for growth at a low price, further reinforcing its attractive valuation. Although return data is not available for a direct comparison with the S&P 500, the substantial difference in valuation ratios suggests that eHealth may offer a compelling investment opportunity relative to its peers....

Is eHealth, Inc. overvalued or undervalued?

2025-11-02 11:08:50

As of 31 October 2025, the valuation grade for eHealth, Inc. has moved from attractive to very attractive, indicating a strong positive shift in its perceived value. The company appears to be undervalued, supported by key ratios such as a P/E ratio of 6, a Price to Book Value of 0.20, and an EV to EBITDA of 0.40. In comparison, its peer Abacus Life, Inc. has a significantly higher P/E ratio of 164.30, highlighting eHealth's relative undervaluation within the industry. Despite recent stock performance showing a year-to-date decline of 44.79% compared to a 16.30% gain in the S&P 500, eHealth's long-term returns over three years of 93.66% versus 76.66% for the benchmark suggest potential for recovery and growth. This combination of low valuation ratios and favorable long-term performance reinforces the argument that eHealth, Inc. is currently undervalued....

Is eHealth, Inc. technically bullish or bearish?

2025-09-20 19:33:23

As of 12 September 2025, the technical trend for eHealth, Inc. has changed from sideways to mildly bearish. The current stance is mildly bearish, driven by daily moving averages indicating bearish momentum and weekly Bollinger Bands showing a bearish signal. While the MACD is mildly bullish on both weekly and monthly time frames, it is countered by the overall bearish signals from the moving averages and Bollinger Bands. The KST shows mild bullishness on the weekly and bullishness on the monthly, but the Dow Theory indicates no trend in both time frames. In terms of performance, eHealth has underperformed the S&P 500 significantly across multiple periods, with a year-to-date return of -57.87% compared to the S&P 500's 12.22%, and a 5-year return of -94.99% versus the S&P 500's 96.61%....

Is eHealth, Inc. overvalued or undervalued?

2025-09-20 18:08:53

As of 7 July 2025, the valuation grade for eHealth, Inc. has moved from attractive to very attractive, indicating a strong improvement in its valuation outlook. The company appears to be undervalued, with a P/E ratio of 6, a Price to Book Value of 0.20, and an EV to EBITDA ratio of 0.40, all suggesting that the stock is trading at a significant discount compared to its earnings and asset value. In comparison, peer Abacus Life, Inc. has a much higher P/E ratio of 164.30, highlighting eHealth's relative undervaluation within the insurance industry. Despite its attractive valuation metrics, eHealth's recent stock performance has been poor, with a year-to-date return of -57.87% compared to the S&P 500's 12.22%. This stark contrast in returns reinforces the notion that the stock may be undervalued, as the market has not yet recognized its potential despite the favorable valuation ratios....

View All News